How Much Does Wegovy Cost?

Wegovy List Price Without Insurance

Wegovy is dispensed in a series of dose-specific prefilled injection pens. The approximate list price for a 4-week supply at the maintenance dose (2.4 mg) is $1,300–$1,450, though this varies by dose tier and changes over time. During the dose escalation period (starting at 0.25 mg), each step requires a different pen and may have slightly different pricing.

These are list prices — what you would pay without insurance coverage or savings program assistance. Many patients pay significantly less with coverage or savings programs; some pay at or near list price without either.

For the most current Wegovy pricing, see Novo Nordisk's NovoCare website or ask your pharmacy directly.

Insurance Coverage for Wegovy

Wegovy is FDA-approved for chronic weight management — a category that has historically faced inconsistent insurance coverage:

• Commercial insurance: Some employer-sponsored plans include weight-management drug coverage; many do not. Coverage is improving as more employers add obesity benefit riders, but it is far from universal. Check your specific plan's formulary.
• Medicare Part D: Traditionally excluded drugs approved only for weight loss. New legislation (TREAT and CMSS Act) is expanding this, but coverage remains limited as of this writing. Check your specific Part D plan.
• Medicaid: Varies significantly by state. Some states cover weight-management medications; many do not.
• Prior authorization: Required by most plans that do cover Wegovy. Your clinician typically submits documentation of BMI and related health conditions to support the request.

See our full GLP-1 insurance coverage guide for a detailed breakdown of coverage patterns.

Novo Nordisk Savings Program for Wegovy

Novo Nordisk offers a savings program for Wegovy that can significantly reduce out-of-pocket cost for eligible patients. Key terms as generally understood (always verify directly with Novo Nordisk as these change):

• Available to commercially insured patients only
• Not available to patients with Medicare, Medicaid, or other federal or state government insurance programs
• Annual savings cap applies
• Patients must be using Wegovy for an approved indication
• Program terms and availability are subject to change without notice

To verify current program terms and eligibility, go directly to NovoCare.com or call the Novo Nordisk savings program line. Do not rely on third-party claims about savings amounts or availability.

Wegovy Cost vs. Zepbound

Both Wegovy and Zepbound are FDA-approved for weight management. At list price, Wegovy tends to be priced higher (~$1,300–$1,450/month) than Zepbound (~$1,000–$1,100/month). However, actual out-of-pocket cost depends heavily on insurance coverage and savings program eligibility — which may differ between the two. Neither is universally "cheaper" for every patient once all factors are considered.

See our Wegovy vs. Zepbound comparison and Zepbound cost guide for more detail.